Abstract
Purpose
In order to avoid the microbiological risks linked to human serum albumin macroaggregates (MAA) used for lung perfusion scintigraphy, we developed a new starch-based Tc-99m potential radiopharmaceutical.
Methods
Microparticles were prepared from oxidised starch coupled to natural polyamine for Tc-99m complexation. Suspensions were formulated as ready-to-use kits for easy one-step labelling procedures.
Results
Particle-size analysis, electron microscopy, and confocal microscopy were performed for microparticle characterisation, and gave a typical size distribution ranging from 7 to 63 µm, with a homogenous population of spherical or oval-shaped microparticles. Radiochemical purity exceeded 95%, and was stable for at least 8 h. When challenged with histidine and human plasma, labelling was also stable. Dynamic scintigraphic acquisitions and biodistribution studies conducted on healthy Wistar rats showed a tracer accumulation with more than 80% of the ID in the lungs after 15 min.
Conclusions
With clinically significant characteristics such as a lung half-life of 3 h, a lung-to-vascular ratio of 900, and a lung-to-liver ratio of 90, starch-based microparticles exhibit all the qualities for an effective new lung perfusion agent.
Similar content being viewed by others
References
Bosson JL, Pouchain D, Bergmann JF. A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices. J Intern Med. 2006;260(2):168–76.
Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28(3):370–2.
Oger E. Incidence of venous thromboembolism: a community-based study in western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000;83(5):657–60.
Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353(9162):1386–9.
van Erkel AR, et al. Spiral CT angiography for suspected pulmonary embolism: a cost-effectiveness analysis. Radiology. 1996;201(1):29–36.
van Rossum AB, et al. Can helical CT replace scintigraphy in the diagnostic process in suspected pulmonary embolism? A retrolective-prolective cohort study focusing on total diagnostic yield. Eur Radiol. 1998;8(1):90–6.
DeMonaco NA, et al. Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med. 2008;121(7):611–7.
Nijkeuter M, Huisman MV. Diagnostic methods in pulmonary embolism. Eur J Intern Med. 2005;16(4):247–56.
Sostman HD, et al. Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPED II study. Radiology. 2008;246(3):941–6.
Worsley DF, Alavi A. Radionuclide imaging of acute pulmonary embolism. Semin Nucl Med. 2003;33(4):259–78.
Perkins AC, Frier M. Bad blood and biologicals: the need for new radiopharmaceutical source materials. Nucl Med Commun. 1999;20(1):1–3.
Delgado A, et al. Radiolabelled biodegradable microspheres for lung imaging. Eur J Pharm Biopharm. 2000;50(2):227–36.
Miroslavov AE, et al. Evaluation of (99m)Tc(CO)(5)I as a potential lung perfusion agent. Nucl Med Biol. 2009;36(1):73–9.
Hunt AP, et al. Preparation of Tc-99m-macroaggregated albumin from recombinant human albumin for lung perfusion imaging. Eur J Pharm Biopharm. 2006;62(1):26–31.
Tsopelas C, Dylan F, Barthomomeusz L. A potential lung perfusion imaging agent of synthetic origin. J Label Compd Radiopharm. 2006;49:367–75.
Rohtman USE, Kagedal SL, Soderberg JL, Agent for intravascular administration. Pharmacia Fine Chemicals AB, 1978. US 4115536.
Denizot B, et al., New compositions based on polysaccharides grafted by polyamine or polysulphurised compounds. Cyclopharma Laboratoires, 2007. WO2009013358.
Taplin GV. The history of lung imaging with radionuclides. Semin Nucl Med. 1979;9(3):178–85.
European Pharmacopeia. 5th ed. 2005, Strasbourg: European Directorate for the Quality of Medicines.
Bellande E, Jallet P, Denizot B, Radiopharmaceutical products and their preparation procedure. Cis Bio International, 2001. WO 01/15746 A1.
Taplin GV, MacDonald NS. Radiochemistry of macroaggregated albumin and newer lung scanning agents. Semin Nucl Med. 1971;1(2):132–52.
Dakhil S, et al. Improved regional selectivity of hepatic arterial BCNU with degradable microspheres. Cancer. 1982;50(4):631–5.
Arfors KE, et al. Temporary intestinal hypoxia induced by degradable microspheres. Nature. 1976;262(5568):500–1.
Forsberg JO. Transient blood flow reduction induced by intra-arterial injection of degradable starch microspheres. Experiments on rats. Acta Chir Scand. 1978;144(5):275–81.
Acknowledgements
We are very grateful to E. Porcher for skilful technical support (Inserm U646, University of Angers, F-49100 Angers, France), to Dr. R. Filmon and R. Mallet (SCIAM, University of Angers, F-49100 Angers, France) for microscopy studies.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lacoeuille, F., Hindré, F., Denizot, B. et al. New starch-based radiotracer for lung perfusion scintigraphy. Eur J Nucl Med Mol Imaging 37, 146–155 (2010). https://doi.org/10.1007/s00259-009-1226-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-009-1226-6